How big is the Europe Oral Anti-Diabetic Drug Market?

The Europe Oral Anti-Diabetic Drug Market size is expected to reach USD 7.36 billion in 2024 and grow at a CAGR of 3.40% to reach USD 8.70 billion by 2029. Read More

What is the current Europe Oral Anti-Diabetic Drug Market size?

In 2024, the Europe Oral Anti-Diabetic Drug Market size is expected to reach USD 7.36 billion. Read More

Who are the key players in Europe Oral Anti-Diabetic Drug Market?

Sanofi, Eli Lilly, Astrazeneca, Astellas and Janseen are the major companies operating in the Europe Oral Anti-Diabetic Drug Market. Read More

What years does this Europe Oral Anti-Diabetic Drug Market cover, and what was the market size in 2023?

In 2023, the Europe Oral Anti-Diabetic Drug Market size was estimated at USD 7.12 billion. The report covers the Europe Oral Anti-Diabetic Drug Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Europe Oral Anti-Diabetic Drug Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Europe Oral Anti-Diabetic DrugCompanies

This report lists the top Europe Oral Anti-Diabetic Drug companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Europe Oral Anti-Diabetic Drug industry.